If you have a 50/50 mix in the same vial, you would withdraw a TOTAL of 40 MCG into the syringe, since there is an equal amount of each peptide in the mix you would be getting 20 MCG of each product
In the latest episode of the Beyond Journal Club podcast from @COREIMpodcast and NEJM Group, the hosts unpack the evolving language of steatotic liver disease and discuss two major trials: MAESTRO-NASH studying resmetirom, the first FDA-approved liver-directed therapy for MASH, and ESSENCE, evaluating semaglutide in biopsy-confirmed disease
Well, that is a good question, for which I do not have a good answer
Jolanda van Hal Semaglutide and tirzepatide extend GLP-1 benefits to liver health, mobility & longevity Jolanda van Hal Key takeaways New research indicates wider GLP-1 benefits beyond weight loss and diabetes, into liver, joint, and aging health
Lifestyle changes are also vital for achieving the best weight loss outcomes with semaglutide